Last update:

Weight management news

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase ...

Bariatric surgery is effective rescue strategy after GLP-1 receptor agonist failure

Bariatric surgery is associated with clinically meaningful two-year weight loss after semaglutide or tirzepatide intolerance or inadequate response, according to a study published online Nov. 3 in the Annals of Surgery.

Obesity drugs could lead to new ways to protect the brain

Drugs such as semaglutide and tirzepatide are already used to treat obesity and type 2 diabetes, but they also influence biological processes important for brain function. In a new review published in Science, researchers ...

Are GLP-1s practical and safe for adolescents with obesity?

GLP-1 medications have become a popular tool for weight loss. But are they appropriate for all age groups? Short for glucagon-like peptide-1, GLP-1s are medications approved by the Food and Drug Administration that treat ...